Volume : 09, Issue : 11, November – 2022

Title:

29.A STUDY ON COVID-19 PANDEMIC: ITS DIAGNOSIS, MANAGEMENT AND POST-COVID CONDITIONS
‬

Authors :

Chaitanya varma Bellamkonda, Varada Chaitanya VInnakota, Dr.Keerthana Tummuri, Dr.Pravilika

Abstract :

There are important human and animal pathogens in the coronavirus family. In Wuhan, a city in the Hubei Province of China, a novel coronavirus was identified as the cause of a cluster of pneumonia cases with no known aetiology around the end of December 2019. The new coronavirus has quickly spread over the world, causing an epidemic in China, a pandemic, and a rising number of cases in many other nations. The 2019 coronavirus disease (COVID-19) is transmitted through the huge droplets coughed and sneezed by both symptomatic patients and asymptomatic people prior to the onset of their symptoms. The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) incubation period is thought to last for 14 days after exposure, usually four to five days. All ages may become infected with SARS-CoV-2, but the majority do so in their middle years and beyond. Many COVID-19 patients experience long-lasting symptoms such as fatigue, shortness of breath, and neurological problems such as cognitive impairment months after the first infection. A large global health burden could result from this syndrome, also known as post-acute condition of SARS-CoV-2 infections (PASC) or post-COVID-19 condition, according to recent research. Fever, a dry cough, lethargy, headache, sore throat, rhinorrhea, conjunctivitis, nausea, vomiting, and diarrhoea are among the typical clinical symptoms. As a result, there are currently no distinctive clinical characteristics that reliably distinguish COVID-19 disease from other upper/lower airway viral infections. In a small percentage of instances, COVID-19 disease may progress to pneumonia, lung failure, and mortality by the end of the first week. Although there are more research looking at the post-COVID-19 condition, there is still no agreement on how this new disease should be defined, diagnosed, and treated in clinical practise, or how the outcomes should be evaluated. For both clinical and research objectives, there is an urgent need to enhance and standardise outcome indicators for this important patient group in order to facilitate data comparability and pooling. in order to harmonise, compare, and improve the quality of data across multiple geographic areas The purpose of this article is to examine the COVID-19 disease, starting with epidemiology and moving on to clinical signs, diagnosis, and its post-COVID consequences before coming to a conclusion and discussing potential therapy options. We advocate for an international effort that involves all significant players, including medical professionals, researchers, subject matter experts, patients, and carers.
Keywords: COVID-19 Condition, Long COVID, Post-acute Condition of SARS-CoV-2 infection

Cite This Article:

Please cite this article in press Chaitanya varma bellamkonda et al, A Study On Covid-19 Pandemic: Its Diagnosis, Management And Post-Covid Conditions.,Indo Am. J. P. Sci, 2022; 09(11).

Number of Downloads : 10

References:

1. National Health Commission of the People’s Republic of China. New coronavirus cases rise to 571 in Chinese mainland. Available from: URL: http://en.nhc.gov.cn/2020-01/23/c_76004.htm. Accessed, January 23, 2020.
2. European Centre for Disease Prevention and Control. Geographical distribution of 2019-nCov cases. Available from: URL: https://www. ecdc.europa.eu/en/geographical-d istribution-2019-ncov-cases. Accessed, January 26, 2020.
3. Sharma, N. (2020). India’s swiftness in dealing with Covid-19 will decide the world’s future, says WHO, Quartz India. Accessed from https://qz.com/india/1824041/who-saysindias-action-on-coronavirus-critical-for-the-world/ on 25th March 2020
4. John Hopkins University (2020). Novel Coronavirus (COVID-19) Cases, provided by JHU CSSE. Accessed from https://github.com/CSSEGISandData/COVID-19 on 6th April 2020.
5. World Health Organization. Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. Availabl from: URL: https:// www.who.int/dg/speeches/detail/who-director-general-s-remarks -at-the-media-briefing-on-2019-ncov-on-11-february-2020. Accessed, February 12, 2020
6. Myers, J. (2020). India is now the world’s 5th largest economy, World Economic Forum.
7. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med 2020; 382(10): 970–1. [CrossRef]
8. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020; 104(3): 246–51. [CrossRef]
9. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-2019). February 16-24, 2020. http://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-finalreport.pdf. Accessed, March 4, 2020.
10. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMoa2002032. [Epub ahead of print].
11. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507–13. [CrossRef]
12. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323(11): 1061–9. [CrossRef]
13. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 – 24 February 2020. Available from: URL: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-themedia-briefing-on-covid-19—24-february-2020. Accessed, February 26, 2020.
14. Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World J Pediatr. 2020 Feb 7. doi: 10.1007/s12519-020-00343-7. [Epub ahead of print] [CrossRef]
15. Dong X, Cao YY, Lu XX, Zhang JJ, Du H, Yan YQ, et al. Eleven Faces of Coronavirus Disease 2019. Allergy. 2020 Mar 20. doi: 10.1111/ all.14289. [Epub ahead of print] [CrossRef]
16. Gupta, R., & Pal, S. K. (2020). Trend Analysis and Forecasting of COVID-19 outbreak in India. medRxiv. Accessed from https://www.medrxiv.org/content/10.1101/2020.03.26.20044511v1 on 3rd April 2020
17. Singh, R., &Adhikari, R. (2020). Age-structured impact of social distancing on theCOVID-19 epidemic in India. arXiv preprint arXiv:2003.12055. Accessed fromhttps://arxiv.org/pdf/2003.12055.pdf on 4th April 2020
18. Sahasranaman, A., & Kumar, N. (2020). Network structure of COVID-19 spread and thelacuna in India’s testing strategy. Available at SSRN 3558548. Accessed fromhttps://arxiv.org/ftp/arxiv/papers/2003/2003.09715.pdf on 3rd April 2020
19. Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide. Bmj, 368.
20. Singhal, T. (2020). A review of coronavirus disease-2019 (COVID-19). The Indian Journal of Pediatrics, 1-6.
21. Sohrabi, C., Alsafi, Z., O’Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., …& Agha, R.(2020). World Health Organization declares global emergency: A review of the 2019novel coronavirus (COVID-19). International Journal of Surgery.
22. Boldog, P., Tekeli, T., Vizi, Z., Dénes, A., Bartha, F. A., &Röst, G. (2020). Risk assessment of novel coronavirus COVID-19 outbreaks outside China. Journal of clinical medicine, 9(2), 571.
23. Covid19India.org (2020a). India Covid-19 Tracker 2020. Accessed from https://www.covid19india.org/ on 7th April 2020
24. Kucharski, A. J., Russell, T. W., Diamond, C., Liu, Y., Edmunds, J., Funk, S., … & Davies, N. (2020). Early dynamics of transmission and control of COVID-19: a mathematical modelling study. The Lancet Infectious Diseases.
25. Weon, B. M. (2020). Doubling time tells how effective Covid-19 prevention works. Med Rxiv. Accessed from https://www.medrxiv.org/content/10.1101/2020.03.26.20044644v1 on 4th April 2020.Google (2020).
26. AlJazeera (2020). India: Coronavirus lockdown sees exodus from cities, Aljazzera NewsChannel. Accessed fromhttps://www.aljazeera.com/programmes/newsfeed/2020/04/india-coronavirus-lockdownsees-exodus-cities-200406104405477.html on 6th April 2020
27. BBC News (2020). Coronavirus: Search for hundreds of people after Delhi prayer meeting, BBC News. Accessed from https://www.bbc.com/news/world-asia-india-52104753on 2nd April 2020
28. Press Trust of India (2020). Coronavirus: 1,445 cases liked to TablighiJamaat event, total crosses 4,000, India Today News. Accessed fromhttps://www.indiatoday.in/india/story/coronavirus-1-445-cases-liked-to-tablighi-jamaatevent-total-crosses-4-000-1663962-2020-04-06 on 7th April 2020.
29. Musil, C. M., Warner, C. B., Yobas, P. K., & Jones, S. L. (2002). A comparison of imputation techniques for handling missing data. Western Journal of Nursing Research, 24(7), 815-829.